NDSIB
UTHR icon

North Dakota State Investment Board’s United Therapeutics UTHR Stock Holding History

North Dakota State Investment Board’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$726K Sell
1,225
-339
-22% -$169K 0.03% 380
2025
Q4 		$762K Buy
+1,564
New +$728K 0.03% 410

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

North Dakota State Investment Board's UTHR Position: Q1 2026 in Review

North Dakota State Investment Board reduced its United Therapeutics (UTHR) stake by 22% in Q1 2026, selling an estimated $169K and leaving 1,225 shares worth $726K. The position accounts for 0.03% of the portfolio, ranked #380.

North Dakota State Investment Board first reported a position in UTHR in Q4 2025 and has held it in 2 quarters since. The position peaked at $762K in Q4 2025. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • North Dakota State Investment Board held 1,225 shares of United Therapeutics worth $726K as of Q1 2026.
  • North Dakota State Investment Board sold 339 United Therapeutics shares in Q1 2026, an estimated $169K.
  • United Therapeutics made up 0.03% of North Dakota State Investment Board's portfolio in Q1 2026, its #380 holding.
  • North Dakota State Investment Board first reported a position in United Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • North Dakota State Investment Board's United Therapeutics position peaked at $762K in Q4 2025.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on North Dakota State Investment Board's 13F filing for Q1 2026, filed 8 May 2026.